Results 11 to 20 of about 68,666 (258)

Radiofrequency Ablation for Adenomyosis [PDF]

Journal of Clinical Medicine, 2023
Adenomyosis is a common benign gynecologic condition characterized by ectopic endometrial glands and stroma in the myometrium causing pain (dysmenorrhea) and abnormal uterine bleeding. New interventional techniques have been introduced over recent years.
Fruscalzo Arrigo, Ioannis Dedes, Arrigo, Fruscalzo, Michael Mueller, David Toub, Arrigo Fruscalzo, Toub, David, Imboden, Sara, Feki, Anis, Sara Imboden, Lanz, Susanne, Vaineau, Cloé, Kolovos, Georgios, Georgios Kolovos, Cloé Vaineau, Susanne Lanz, Anis Feki, Mueller, Michael D, Dedes, Ioannis   +18 more
core   +3 more sources

Radiofrequency ablation [PDF]

Cancer, 2004
Dr. Kenneth K. Tanabe solicited opinions from two interventional radiologists and two surgeons who have made groundbreaking innovations in the field of radiofrequency ablation. He asked each to address four questions, and the responses succinctly describe the current state and the future of radiofrequency ablation.
Kenneth K, Tanabe, Steven A, Curley, Gerald D, Dodd, Allan E, Siperstein, S Nahum, Goldberg   +4 more
  +7 more sources

Radiofrequency ablation devices [PDF]

VideoGIE, 2017
The use of RFA as a treatment modality in gastrointestinal endoscopy is expanding. RFA is frequently used in combination with focal EMR for the treatment of dysplastic BE and as standalone therapy for flat BE. Its efficacy in the treatment of esophageal squamous dysplasia appears promising.
Udayakumar Navaneethan, MD, Nirav Thosani, MD, Adam Goodman, MD, FASGE, Michael Manfredi, MD, Rahul Pannala, MD, MPH, Mansour A. Parsi, MD, FASGE, Zachary L. Smith, DO, Shelby A. Sullivan, MD, Subhas Banerjee, MD, FASGE, John T. Maple, DO, FASGE   +9 more
openaire   +3 more sources

Radiofrequency Ablation of Cancer [PDF]

CardioVascular and Interventional Radiology, 2004
Radiofrequency ablation (RFA) has been used for over 18 years for treatment of nerve-related chronic pain and cardiac arrhythmias. In the last 10 years, technical developments have increased ablation volumes in a controllable, versatile, and relatively inexpensive manner. The host of clinical applications for RFA have similarly expanded.
Marc, Friedman, Igor, Mikityansky, Anthony, Kam, Steven K, Libutti, McClellan M, Walther, Ziv, Neeman, Julia K, Locklin, Bradford J, Wood   +7 more
openaire   +2 more sources

Percutaneous radiofrequency ablation for hepatic tumors: factors affecting baseline impedance [PDF]

, 2021
PurposeWe aimed to evaluate factors that affect baseline impedance of percutaneous radiofrequency ablation.MethodsIn this retrospective study, we analyzed 51 patients with 55 hepatic tumors from November 2015 until April 2018.
Sungjun Hwang, Suk Hyun-Bae, Yoon Kyung-Lee, Jung Wook-Seo, Byung Hoon-Lee   +4 more
core   +1 more source

Hepatic Radiofrequency Ablation [PDF]

Archives of Surgery, 2002
Hepatic radiofrequency ablation (RFA) is effective in treating patients with unresectable hepatic malignancies.Case series of 123 patients with unresectable hepatic tumors or tumors with histological findings not traditionally treated by means of hepatic resection were considered for hepatic RFA.
David A, Iannitti, Damian E, Dupuy, William W, Mayo-Smith, Brian, Murphy   +3 more
openaire   +2 more sources

Multimodality Treatment with Conventional Transcatheter Arterial Chemoembolization and Radiofrequency Ablation for Unresectable Hepatocellular Carcinoma [PDF]

, 2011
Background/Aims: To evaluate the efficacy of multimodality treatment consisting of conventional transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) in patients with non-resectable and non-ablatable hepatocellular carcinoma ...
Rentsch, M., P. Paprottka, F.T. Kolligs, M. Rentsch, Paprottka, P., T.F. Jakobs, Kolligs, F. T., Reiser, Maximilian F., Jakobs, T. F., Ashoori, N., F. Bamberg, Bamberg, F., Trumm, C., N. Ashoori, C. Trumm, M.F. Reiser   +15 more
core   +1 more source

Radiofrequency Ablation for Colorectal Cancer Liver Metastases: Outcomes and Prognostic Factors Associated with Survival

, 2023
Background: To determine the long-term outcomes of radiofrequency ablation with respect to overall survival, disease-free survival, and complications in patients with colorectal cancer liver metastases.
Okan Akhan, Türkmen Çiftçi, Devrim Akıncı, ÇİFTÇİ, Türkmen Turan, Emre Ünal, ÜNAL, EMRE, METİN, Yavuz, Seray Akçalar, AKINCI, Devrim, AKHAN, Okan, Akçalar, Seray, Yavuz Metin   +11 more
core   +1 more source

Multimodality Treatment for Early-Stage Hepatocellular Carcinoma: A Bridging Therapy for Liver Transplantation [PDF]

, 2012
Purpose: To evaluate the efficiency of a multimodality approach consisting of transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) as bridging therapy for patients with hepatocellular carcinoma (HCC) awaiting orthotopic liver
Rentsch, M., P. Paprottka, F.T. Kolligs, Siegert, S., Kolligs, F. T., R.T. Hoffmann, Hoffmann, Ralf-Thorsten, Reiser, Maximilian F., Paprottka, Philipp M., D’Anastasi, Melvin, Jakobs, Tobias F., N. Ashoori, J.A. Al-Tubaikh, M.F. Reiser, Ashoori, Nima, M. Rentsch, Al-Tubaikh, J. A., Paprottka, P., Al-Tubaikh, Jarrah Ali, T.F. Jakobs, Kolligs, Frank T., Rentsch, Markus, Peporte, A., Hoffmann, R. T., M. D’Anastasi, Jakobs, T. F., D'Anastasi, M., Ashoori, N., Siegert, Sabine, S. Siegert, Bamberg, Fabian, F. Bamberg, Bamberg, F., A. Peporte   +33 more
core   +1 more source

Radiofrequency ablation of lymphoma

Blood, 2006
Percutaneous minimally invasive radiofrequency (RF) ablation has not been described for lymphoma. This image-guided modality is presented in 3 different settings for the treatment of refractory lymphoma. The first patient received RF ablation for the curative treatment of a solitary residual hepatic mass following rituximab-based chemotherapy for a ...
Deepak, Sudheendra, Mara M, Barth, Upendra, Hegde, Wyndham H, Wilson, Bradford J, Wood   +4 more
openaire   +3 more sources